HomeTNGX • NASDAQ
add
Tango Therapeutics Inc
Previous close
$3.84
Year range
$2.70 - $13.01
Market cap
425.51M USD
Avg Volume
2.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 11.61M | 8.15% |
Operating expense | 11.22M | 21.86% |
Net income | -29.17M | -31.01% |
Net profit margin | -251.29 | -21.14% |
Earnings per share | -0.27 | -17.39% |
EBITDA | -32.26M | -28.96% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 293.28M | -18.51% |
Total assets | 352.42M | -17.70% |
Total liabilities | 123.24M | -18.70% |
Total equity | 229.17M | — |
Shares outstanding | 107.42M | — |
Price to book | 1.80 | — |
Return on assets | -22.40% | — |
Return on capital | -29.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -29.17M | -31.01% |
Cash from operations | -33.39M | -7.24% |
Cash from investing | 32.57M | 157.48% |
Cash from financing | 2.40M | -97.01% |
Net change in cash | 1.58M | 121.04% |
Free cash flow | -20.89M | 5.62% |
About
Founded
2017
Headquarters
Website
Employees
140
